Related Experiment Video
Updated: Jun 22, 2026
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
TRPA1 as Target in Myocardial Infarction
Clara Hoebart1, Attila Kiss2, Patrick M Pilz2
1Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Abstract:
Transient receptor potential cation channel subfamily A member 1 (TRPA1), an ion channel primarily expressed on sensory neurons, can be activated by substances occurring during myocardial infarction. Aims were to investigate whether activation, inhibition, or absence of TRPA1 affects infarcts and to explore underlying mechanisms. In the context of myocardial infarction, rats received a TRPA1 agonist, an antagonist, or vehicle at different time points, and infarct size was assessed. Wild type and TRPA1 knockout mice were also compared in this regard. In vitro, sensory neurons were co-cultured with cardiomyocytes and subjected to a model of ischemia-reperfusion. Although there was a difference between TRPA1 activation or inhibition in vivo, no experimental group was different to control animals in infarct size, which also applies to animals lacking TRPA1. In vitro, survival probability of cardiomyocytes challenged by ischemia-reperfusion increased from 32.8% in absence to 45.1% in presence of sensory neurons, which depends, at least partly, on TRPA1. This study raises doubts about whether TRPA1 is a promising target to reduce myocardial damage within a 24 h period. The results are incompatible with relevant enlargements of infarcts by TRPA1 activation or inhibition, which argues against adverse effects when TRPA1 is targeted for other indications.
Insights
Transient receptor potential cation channel subfamily A member 1 (TRPA1) activation or absence did not alter myocardial infarct size in vivo. However, TRPA1 in sensory neurons partially protected cardiomyocytes from ischemia-reperfusion injury in vitro.
Area of Science:
- Cardiology
- Neuroscience
- Ion Channel Physiology
Background:
- Transient receptor potential cation channel subfamily A member 1 (TRPA1) is expressed on sensory neurons and activated by myocardial infarction indicators.
- TRPA1's role in myocardial infarction pathogenesis and its potential as a therapeutic target remain unclear.
Purpose of the Study:
- To investigate the effect of TRPA1 activation, inhibition, or absence on myocardial infarct size.
- To explore the underlying mechanisms of TRPA1's influence on myocardial infarction and cardiomyocyte survival.
Main Methods:
- In vivo studies involved administering TRPA1 agonists or antagonists to rats undergoing myocardial infarction and assessing infarct size.
- TRPA1 knockout mice were compared to wild-type mice.
- In vitro experiments co-cultured sensory neurons with cardiomyocytes subjected to ischemia-reperfusion.
Main Results:
- No significant differences in infarct size were observed in rats treated with TRPA1 modulators or in TRPA1 knockout mice compared to controls.
- In vitro, the presence of sensory neurons significantly increased cardiomyocyte survival probability after ischemia-reperfusion, partly mediated by TRPA1.
- TRPA1 activation or inhibition did not lead to relevant infarct size enlargement in vivo.
Conclusions:
- TRPA1 does not appear to be a promising therapeutic target for reducing myocardial damage within a 24-hour period post-infarction.
- TRPA1's role in sensory neurons may offer partial protection to cardiomyocytes during ischemia-reperfusion, suggesting a localized protective effect.
- The findings argue against adverse effects of TRPA1 targeting for other indications due to its lack of impact on infarct size.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
